BYD
26.2.2024 03:44:26 CET | Business Wire | Press release
BYD, the world’s leading manufacturer of new energy vehicles and power battery, proudly unveils the first pure electric supercar model U9 under its high-end sub-brand, YANGWANG, priced at 1.68 million RMB, and announced the delivery will start in this summer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240225803324/en/
YANGWANG U9 (Photo: Business Wire)
Adopting the “Time Gate” design language, the YANGWANG U9 embodies a distinctive aesthetic, characterized by unique proportions, tension, and power, reflecting its identity as a pure electric supercar.
Robust Technologies Shapes The Track-ready, Street-savvy, and Playful U9
The YANGWANG U9 is powered by two core technologies, the e4 platform and the DiSus-X Intelligent Body Control System, revolutionizing the pure electric supercar segment, seamlessly integrating track performance, street adaptability, and playful features.
The e4 Platform is a power system with four independent electric motors as its core, featuring agile and precise and four-wheel independent torque output control, bringing users the ultimate in safety, performance, and experience. The YANGWANG U9 packs a whopping 1,300 horsepower and a maximum torque of 1680N·m.
The BYD DiSus-X Intelligent Body Control System is another proprietary breakthrough. The first deployment of the BYD DiSus-X Intelligent Body Control System enables the YANGWANG U9 to achieve the maximum adjustable suspension travel of up to 75mm, while its peak single-axis lifting speed of up to 500mm/s, enabling instantaneous lifting force of over 1 ton and facilitating the remarkable leap-up of the U9. Those features deliver unparalleled driving experience in diverse driving scenarios like braking, acceleration, cornering, and road impacts, greatly enhancing vehicle agility and comfort for both drivers and passengers. In addition to these, YANGWANG U9 can effortlessly dance to music with just a click.
Unprecedented Performance Redefines Pure Electric Supercar
In recent tests, the YANGWANG U9 reaches a top speed of 309.19 km/h and can sprint from 0 to 100 km/h in just 2.36 seconds, with 0-400m acceleration in only 9.78 seconds. Besides, after rigorous track testing, the U9 has fine-tuned its thermal management system to better resist high temperatures, resulting in a 100% increase in maximum cooling capacity. The Blade Battery facilitates discharging and cooling functions and Dual Plug-in Ultra-fast charging technology boasts a maximum charging power of 500 kW. Additionally, YANGWANG U9 is equipped with 12 sets of active and passive aerodynamic packages to reduce drag coefficient and enhance heat dissipation efficiency.
The YANGWANG U9 boasts the Super Carbon-fiber Cabin, a structure made of different materials, and the next-generation CTB technology. And it contributes to unprecedented torsional stiffness of 54425N·m/deg and the single-side compressive load of the roof exceeds 11 tons, ensuring comprehensive travel safety.
Intelligent Cabin Creates Unparalleled Driving Experience
The YANGWANG U9 is equipped with the DiLink150 intelligent platform, powered by customized 4nm 5G chips. Specifically designed for track driving, it boasts an intelligent racing assistantance, providing extensive track driving services with detailed information on nearly 30 racetracks across China.
Inside, the YANGWANG U9’s cockpit features two 14-way adjustable seats to offer drivers and passengers with better experience. It also boasts the Dynaudio Evidence Series high-end audio system, offering an immersive auditory experience.
With BYD's adhering commitments to innovation and sustainability, YANGWANG redefines the essence of the supercar with its cutting-edge technologies and superior performance, offering uncompromising safety and an incomparable driving experience to users.
About BYD
BYD is a multinational high-tech company devoted to leveraging technological innovations for a better life. Founded in 1995 as a rechargeable battery maker, BYD now boasts a diverse business scope covering automobiles, rail transit, new energy, and electronics, with over 30 industrial parks in China, the United States, Canada, Japan, Brazil, Hungary, and India. From energy generation and storage to its applications, BYD is dedicated to providing zero-emission energy solutions that reduce global reliance on fossil fuels. Its new energy vehicle footprint now covers 6 continents, over 70 countries and regions, and more than 400 cities. Listed in both Hong Kong and Shenzhen Stock Exchanges, the company is known to be a Fortune Global 500 enterprise that furnishes innovations in pursuit of a greener world.
For more information, please visit www.bydglobal.com.
About BYD Auto
Founded in 2003, BYD Auto is the automotive subsidiary of BYD, a multinational high-tech company devoted to leveraging technological innovations for a better life. Aiming to accelerate the green transition of the global transportation sector, BYD Auto focuses on developing pure electric and plug-in hybrid vehicles. The company has mastered the core technologies of the entire industrial chain of new energy vehicles, such as batteries, electric motors, and electronic controllers. It has witnessed in recent years significant technological advancements, including the Blade Battery, DM-i Super Hybrid Technology, e Platform 3.0, CTB Technology, e4 Platform, BYD DiSus Intelligent Body Control System, and DMO super hybrid system. The company is the world's first carmaker to stop the production of fossil-fueled vehicles on the EV shift and has remained top of new energy passenger vehicle sales in China for 11 years in a row. For more information, please visit www.byd.com.
Please download the press kit via https://we.tl/t-r0AB5Tylah
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240225803324/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally25.2.2026 08:07:00 CET | Press release
The investor consortium comprising the Paris-based Next Generation Fuels Industrial & Technological fund Calderion (Audacia), alongside infrastructure developer Terravent and WenCo Family Office, announces the closing of a strategic double-digit million-euro financing round for Berlin-based Graforce GmbH. The investment is dedicated to the industrial scale-up of Graforce’s proprietary plasma pyrolysis technology, addressing the growing global demand for cost-efficient low-carbon hydrogen, syngas, and carbon removal solutions that are compatible with existing industrial infrastructures. Disruptive alternative to conventional processes Graforce’s technology aims at replacing CO₂-intensive legacy routes such as steam reforming and classical gasification. By applying plasma to methane, biogas, flare gas, and landfill gas, the process converts these streams into their valuable molecular components instead of emitting them. The result is a high-efficiency production of clean hydrogen and syn
Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy25.2.2026 08:00:00 CET | Press release
CE Marking enables marketing and clinical use of the world’s first and only LINAC vault-ready proton therapy system across the European Union Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has received CE Marking under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone enables the marketing, sale, and clinical use of the MEVION S250-FIT system throughout the European Union, building on the system’s existing U.S. FDA 510(k) clearance granted in September 2025. The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION S250-FIT dramatically reduces the cost, complexity, and timeline traditionally associated with proton therapy adoption. This opens a new pathway for hospitals and cancer centers a
Bureau Veritas:Sector-Leading Organic Revenue Growth of 6.5% in FY 202525.2.2026 07:30:00 CET | Press release
Strong margin improvement to 16.3% in FY 2025Positive growth outlook with continued margin expansion in 2026New EUR 200 million share buyback Bureau Veritas (BOURSE:BVI): 2025 key figures1 › Full-year revenue of EUR 6,466.4 million, up 6.5% organically (with 6.3% organic growth in Q4). At constant currency, the growth was up 7.3% year-on-year and up 3.6% on a reported basis, › Adjusted operating profit of EUR 1,052.9 million, up 5.7% versus EUR 996.2 million in FY 2024, representing an adjusted operating margin of 16.3%, up 32 basis points year-on-year and up 51 basis points at constant currency, › Operating profit of EUR 992.4 million, up 6.3% versus EUR 933.4 million in FY 2024, › Adjusted net profit of EUR 631.4 million, up 1.7% versus EUR 620.7 million in FY 2024, › Adjusted EPS stood at EUR 1.42 in 2025, with a 2.8% increase versus FY 2024 (EUR 1.38 per share) and up 9.2% at constant currency, › Attributable net profit of EUR 588.0 million, up 3.3% versus EUR 569.4 million in FY 2
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics25.2.2026 07:00:00 CET | Press release
Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane®syringe for use with a range of Restylane NASHA® lidocaine products in multiple indications in the face and in the hands1-3 Developed in collaboration with aesthetic practitioners, its innovative ergonomic design features a cushioned finger grip and thumb rest, to improve practitioner experience through better injection comfort and control, helping them deliver consistently premium results 4-7 The syringe’s carton packaging is the first in the industry to be made from 100% recyclable paper, and reaffirms Galderma’s commitment to sustainability and environmental responsibility 8 These approvals demonstrate Galderma’s strong heritage in Injectable Aesthetics, and its commitment to continuing to drive innovation in the field Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-ar
Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis25.2.2026 07:00:00 CET | Press release
Preclinical proof-of-concept data in GM2 gangliosidosis demonstrated survival benefit, functional improvement and target engagementResults are published in the 7 January issue of the Journal of Inherited Metabolic DiseaseNizubaglustat is currently in Phase 3 registrational studies in GM1/GM2 gangliosidoses and Niemann-Pick type C disease (NPC) Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept preclinical data with its lead product, nizubaglustat, in GM2 gangliosidosis. The data, published in the 7 January issue of the Journal of Inherited Metabolic Disease in collaboration with the laboratory of Dr. Jagdeep Walia, Department of Pediatrics, Queen's University, Kingston, Canada, reinforce nizubaglustat’s potential to address unmet needs in rare LSDs and build on existing preclinical and clinical evidence. The preclinical study tested nizubaglustat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom